Hochschulschrift
The molecular basis of dystrophic Epidermolysis bullosa : mutation detection and study of clinical, biochemical and molecular findings in 29 patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erscheinungsjahr an der Haupttitelstelle: 2005
Freiburg (Breisgau), Univ., Diss., 2006
- Schlagwort
-
Epidermolysis bullosa ; Epidermolysis bullosa dystrophica rezessiva ; Epidermolysis bullosa dystrophicans ; Epidermolysis bullosa hereditaria
Hautkrankheit
Dermatologie
- Urheber
- URN
-
urn:nbn:de:bsz:25-opus-26717
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Molecular and genetic mechanisms in junctional epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Molecular and genetic mechanisms in junctional epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Molecular and genetic mechanisms in junctional epidermolysis bullosa
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa